Genesis Therapeutics

Genesis Therapeutics (now Genesis Molecular AI) develops GEMS, an AI-powered operating system for drug discovery leveraging advanced machine learning and physics-based research. The platform uses foundation models like Pearl, including 3D diffusion models, to help scientists discover and design potent, selective drug candidates against difficult protein targets with unprecedented speed. It is intended for pharmaceutical companies, biotech firms, and researchers seeking to accelerate the invention of new medicines, especially for challenging molecular targets.